Financial Network Wealth Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-79
Closed -$14.5K 785
2025
Q4
$14.5K Sell
79
-4
-5% -$702 0.02% 430
2025
Q3
$12.7K Buy
83
+8
+11% +$1.21K 0.01% 422
2025
Q2
$10.5K Hold
75
0.01% 433
2025
Q1
$11K Buy
+75
New +$10.9K 0.01% 403
2024
Q4
Sell
-148
Closed -$23.1K 514
2024
Q3
$23.1K Buy
+148
New +$23.9K 0.02% 353

Other funds holding AZN

Financial Network Wealth Advisors's AZN Position: Q1 2026 in Review

Financial Network Wealth Advisors sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 79 shares — an estimated $14.5K sold.

Financial Network Wealth Advisors first reported a position in AZN in Q3 2024 and held it in 5 quarters. The position peaked at $23.1K in Q3 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Financial Network Wealth Advisors reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Financial Network Wealth Advisors sold 79 AstraZeneca shares in Q1 2026, an estimated $14.5K.
  • Financial Network Wealth Advisors first reported a position in AstraZeneca in Q3 2024 and held it in 5 quarters.
  • Financial Network Wealth Advisors's AstraZeneca position peaked at $23.1K in Q3 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.